Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 841

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 841
---
F-83</div>

TUHURA BIOSCIENCES, INC AND SUBSIDIARIES Notes to the consolidated financial statements For the years ended December 31, 2024, and 2023

| Less accumulated depreciation and amortization |     | December 31,2024 |  2,210,813 
 (2,087,447 | ) |     | December 31,2023 |  2,152,906 
 (1,970,736 | ) |
|:-----------------------------------------------|:----|:-----------------|-----------:|:--|:----|:-----------------|-----------:|:--|
|                                                |     | $                |    123,366 |   |     | $                |    182,170 |   |

Depreciation and amortization of property and equipment totaled approximately $ 117,000and $ 177,000for the years ended December 31, 2024, and 2023, respectively.

Note 9-Accountspayable and accrued expenses

Accounts payable and accrued expenses consist of the following as of December 31, 2024, and 2023:

|                        |     |            | December 31,2024 |     |            | December 31,2023 |
|:-----------------------|:----|-----------:|-----------------:|:----|-----------:|-----------------:|
| Trade accounts payable |     |          $ |        3,152,816 |     |          $ |        1,866,762 |
| Accrued compensation   |     |            |        1,161,650 |     |            |        1,415,397 |
| Other accrued expenses |     |            |          855,700 |     |            |          156,400 |
|                        |     | $5,170,166 |                  |     | $3,438,559 |                  |

Note 10-Convertiblepromissory notes On various dates beginning on December 11, 2023 through September 18, 2024, the Company completed a private placement in which the Company issued Convertible Promissory Notes (the “Notes”) with various entities at various amounts for an aggregate of $ 31,253,000. The Notes bear interest at a rate of twenty percent ( 20%) per annum and were scheduled to mature on the second anniversary of the issuance date. In addition, the investors in the private placement